DEF 14A

Company

REVIVA PHARMACEUTICALS HOLDINGS, INC.

Filed

September 9, 2020

Period of Report

September 24, 2020

Accession Number

0001104659-20-103469

A DEF 14A is a proxy statement sent to shareholders before an annual meeting. It covers executive compensation, board elections, and shareholder votes. Learn more about DEF 14A filings →